Earnings

Dogwood Therapeutics posts Q4 loss of $0.26/share, 69.8% narrower than the $0.86 consensus, as clinical-stage biotech reduces burn rate.

General Mills Q3 EPS of $0.64 missed estimates by 12.1% as strategic pricing investments weighed on results; management reaffirms guidance,…

Star Equity posts Q4 loss of $0.10 per share, missing estimates by 152.6%, despite 69% revenue growth to $56.8M.

Ovid Therapeutics swings to $0.06 EPS profit versus -$0.10 estimate, reversing year-ago loss with $9.7M net income on $700K revenue.

Weibo Corporation (WB) delivered Q4 2025 adjusted earnings of $0.25 per share, below analysts' $0.32 forecast (miss by 20.8%).

Trevi Therapeutics narrows Q4 loss to $0.06 per share, beating estimates by 37% as the pre-revenue biotech maintains unanimous analyst…

Solaris Energy Infrastructure beats adjusted EPS estimates by 41.5% but misses on revenue as capital spending drives negative free cash…

Kestra Medical posted a slightly wider-than-expected Q3 loss of $0.61/share, but revenue surged 63% year-over-year to top estimates.

HealthEquity's Q4 GAAP EPS of $0.58 missed estimates by 35.4% despite revenue topping consensus, with fiscal 2027 guidance now in…

Titan America's Q4 EPS of $0.26 beat estimates by 6.7%, though revenue of $405.7M missed consensus as margin expansion offset…